Anthracycline - PharmaKB

Anthracycline

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2862 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Breast neoplasms	D001943	EFO_0003869	C50	85	422	210	18	107	784
Lymphoma	D008223	—	C85.9	85	263	110	11	33	450
Leukemia	D007938	—	C95	83	179	102	21	24	363
Myeloid leukemia acute	D015470	—	C92.0	108	163	77	6	18	320
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	31	98	58	21	17	210
Sarcoma	D012509	—	—	56	106	45	1	21	206
Large b-cell lymphoma diffuse	D016403	—	C83.3	45	98	34	2	6	158
Non-hodgkin lymphoma	D008228	—	C85.9	36	88	40	3	12	157
Neoplasms	D009369	—	C80	65	55	16	3	23	147
Myeloid leukemia	D007951	—	C92	49	78	34	4	11	146

Show 42 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Triple negative breast neoplasms	D064726	—	—	22	88	18	—	10	128
Ovarian neoplasms	D010051	EFO_0003893	C56	23	28	16	—	1	61
Neoplasm metastasis	D009362	EFO_0009708	—	13	28	11	—	2	49
Recurrence	D012008	—	—	20	21	8	—	4	48
Stomach neoplasms	D013274	EFO_0003897	C16	8	28	11	—	5	47
Neuroblastoma	D009447	EFO_0000621	—	8	21	15	—	2	46
Osteosarcoma	D012516	—	—	9	17	10	—	7	36
Monocytic leukemia acute	D007948	—	—	10	17	11	—	1	35
Myelomonocytic leukemia acute	D015479	—	C92.5	10	17	10	—	1	35
Erythroblastic leukemia acute	D004915	EFO_1001257	C94.0	8	14	10	—	1	30

Show 138 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Blast crisis	D001752	—	—	3	9	—	—	—	12
Invasive hydatidiform mole	D002820	—	D39.2	—	9	—	—	1	10
Plasmablastic lymphoma	D000069293	—	C83.3	6	6	—	—	—	10
Acute disease	D000208	—	—	4	3	—	—	—	7
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	4	4	—	—	—	7
Non-small-cell lung carcinoma	D002289	—	—	2	4	—	—	1	7
Head and neck neoplasms	D006258	—	—	5	6	—	—	—	7
Myeloid leukemia chronic-phase	D015466	—	—	3	3	—	—	—	6
Thyroid neoplasms	D013964	EFO_0003841	—	2	6	—	—	—	6
Aids-related lymphoma	D016483	EFO_1001365	—	2	4	—	—	—	6

Show 129 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Appendiceal neoplasms	D001063	EFO_0003880	C18.1	2	—	—	—	1	3
Cystadenocarcinoma	D003536	—	—	2	—	—	—	—	2
Neoplasms by histologic type	D009370	—	—	2	—	—	—	—	2
Pregnancy	D011247	EFO_0002950	Z33.1	1	—	—	—	1	2
Chromosome aberrations	D002869	Orphanet_68335	—	1	—	—	—	1	2
Female genital neoplasms	D005833	—	—	2	—	—	—	—	2
Castration-resistant prostatic neoplasms	D064129	—	—	1	—	—	—	—	1
Leukemia myeloid chronic atypical bcr-abl negative	D054438	—	C92.2	1	—	—	—	—	1
Thrombocytosis	D013922	—	D75.83	1	—	—	—	—	1
Skin neoplasms	D012878	EFO_0004198	C44	1	—	—	—	—	1

Show 9 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Alopecia	D000505	—	L64	—	—	—	—	5	5
Alopecia areata	D000506	EFO_0004192	L63	—	—	—	—	4	4
Peripheral nervous system diseases	D010523	—	G64	—	—	—	—	3	3
Myocardial infarction	D009203	EFO_0000612	I21	—	—	—	—	3	3
Fatigue	D005221	—	R53.83	—	—	—	—	2	2
Wounds and injuries	D014947	—	T14.8	—	—	—	—	2	2
Carcinoid tumor	D002276	—	D3A.00	—	—	—	—	2	2
Oncogenes	D009857	—	—	—	—	—	—	2	2
Erectile dysfunction	D007172	EFO_0004234	F52.21	—	—	—	—	2	2
Diabetic neuropathies	D003929	EFO_1000783	—	—	—	—	—	2	2

Show 48 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—